Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SENEKA: SZC to Optimize RAASi Therapy in Elderly HF and CKD Patients
NCT06578078Phase 3Recruiting
- Sponsor
- INCLIVA Biomedical Research Institute
- Start
- Oct 2024
- Primary completion
- Dec 2026
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of sodium zirconium cyclosilicate in heart failure (HF), chronic kidney disease (CKD), hyperkalemia, sponsored by INCLIVA Biomedical Research Institute. Started Oct 2024; status: recruiting.
02
Drugs
sodium zirconium cyclosilicate
03
Conditions
heart failure (HF)chronic kidney disease (CKD)hyperkalemia
Beyond the preview
Go deeper on NCT06578078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06578078.